✨
AI Summary
- Rocket Pharmaceuticals CEO Dr. Gaurav Shah discusses FDA clinical holds on gene therapy trials.
- He offers insights into why these holds occur and their impact.
- The discussion touches on takeaways from the FDA's CTGTAC meeting.